FDA Inspection 800781 — Carter BloodCare at Hulen

Carter BloodCare at Hulen — FEI 3000719944

The FDA completed an inspection of Carter BloodCare at Hulen on September 27, 2012 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Worth, TX (United States)